Method of manufacturing crystalline and amorphous forms of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and thermoplastic resin therefrom

US12540215B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12540215-B2
Application numberUS-202217587571-A
CountryUS
Kind codeB2
Filing dateJan 28, 2022
Priority dateFeb 27, 2019
Publication dateFeb 3, 2026
Grant dateFeb 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for forming a crystalline form or an amorphous form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and thermoplastic resin therefrom. According to one embodiment, a crystal solvate form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, which contains in its crystals from 0.3 to 1.2 mol of an organic solvent per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, where the organic solvent is selected from the group consisting of methanol, toluene, and methyl ethyl ketone.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A method of manufacturing a crystalline form A of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, wherein the crystalline form A comprises less than 0.1 mol of organic solvents per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and which in an X-ray powder diffraction diagram at 22° C. and Cu-Kα radiation displays the following three reflections, quoted as 20 values: 20.9±0.2°, 21.4±0.2° and 23.7±0.2°; and at least 3 of the following reflections, quoted as 2θ values: 6.5±0.2°, 8.6±0.2°, 11.0±0.2°, 13.2±0.2°, 14.9±0.2°, 16.2±0.2°, 17.3±0.2°, 17.8±0.2°, 18.4±0.2° and 19.0±0.2°; and wherein the method comprises determining the contents of the solvent in the crystalline solvate form by gas chromatography and obtaining the X-ray powder diffraction diagram of the crystalline solvate form at 22° C. using Cu-Kα radiation. 2 . The method of manufacturing the crystalline form of claim 1 , which in a DSC recorded according to ISO 11357-3:2018 at a heating rate of 20 K/min shows an endothermic peak having an onset in the range of 112-114° C. and a peak maximum in the range from 124-126° C. 3 . A method of manufacturing a crystalline form C of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, wherein the crystalline form C comprises less than 0.1 mol of organic solvents per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and which in an X-ray powder diffraction diagram at 22° C. and Cu-Kα radiation displays the following three reflections, quoted as 2θ values: 5.1±0.2°, 7.6±0.2° and 21.0±0.2°; and at least 3 of the following reflections, quoted as 2θ values: 8.2±0.2°, 9.2±0.2°, 10.4±0.2°, 10.8±0.2°, 11.6±0.2°, 12.8±0.2°, 13.4±0.2°, 14.5±0.2°, 15.2±0.2°, 15.6±0.2°, 16.6±0.2°, 17.4±0.2°, 17.9±0.2°, 18.5±0.2°, 19.2±0.2°, 19.9±0.2°, 20.4±0.2°, 21.8±0.2°, 22.2±0.2°, 22.6±0.2°, 13.4±0.2°, 24.0±0.2°, 25.7±0.2°, 27.3±0.2° and 27.9±0.2°; and wherein the method comprises determining the contents of the solvent in the crystalline solvate form by gas chromatography, and obtaining the X-ray powder diffraction diagram of the crystalline solvate form at 22° C. using Cu-Kα radiation. 4 . The method of manufacturing the crystalline form of claim 3 , which in a DSC recorded according to ISO 11357-3:2018 at a heating rate of 20 K/min shows an endothermic peak having an onset in the range of 112-114° C. and a peak maximum in the range from 124-126° C. 5 . The method of manufacturing the crystalline form of any one of claim 1 or 3 , wherein the crystals have an aspect ratio of at most 5:1.

Assignees

Inventors

Classifications

  • Crystalline forms, e.g. polymorphs · CPC title

  • Lenses · CPC title

  • Preparation processes · CPC title

  • Polyesters containing oxygen in the form of ether groups (C08G63/42, C08G63/58 take precedence) · CPC title

  • the aromatic ring being a naphthalene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12540215B2 cover?
Methods for forming a crystalline form or an amorphous form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl and thermoplastic resin therefrom. According to one embodiment, a crystal solvate form of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-binaphthyl, which contains in its crystals from 0.3 to 1.2 mol of an organic solvent per 1 mol of 6,6′-diphenyl-2,2′-bis(2-hydroxyethoxy)-1,1′-…
Who is the assignee on this patent?
Mitsubishi Gas Chemical Co
What technology area does this patent fall under?
Primary CPC classification C08G63/672. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).